for educational and safety purposes
Every compound in the sci-wiki that affects gastric emptying; the ones you can source are floated to the front, then the reference-only entries. Tap any for the full entry, mechanism, and outlets.
4 sourced · 1 reference
Orforglipron is a non-peptide, small-molecule GLP-1 receptor agonist taken as a once-daily pill. Eli Lilly is developing it (code LY3502970) for type 2 diabetes and obesity; it is not approved and remains in late-stage trials as of 2026. What makes it notable is the chemistry, not a new mechanism. Because it is a small molecule rather than a peptide, it is absorbed from the gut on its own, without an absorption enhancer and without the food and water restrictions that oral semaglutide requires. In phase 3 trials it lowered blood sugar and body weight meaningfully, though by less than the strongest injectables, with the gastrointestinal side effects typical of the class.
Apple cider vinegar (ACV) is just fermented apple juice; the active ingredient is acetic acid (the sour compound that makes any vinegar a vinegar). The unfiltered bottles carry "the mother," a cloudy tangle of proteins, enzymes, and beneficial bacteria left over from fermentation. The honest picture is that the evidence is modest. The single best-supported effect is that a spoonful taken with a carb-heavy meal blunts the post-meal blood-sugar spike, because acetic acid slows how fast your stomach empties and how fast carbohydrates get digested. There are smaller, less consistent hints toward slightly reduced appetite and modest weight or digestion effects, but nothing dramatic. The one thing that should not be soft-pedaled is the safety angle: straight vinegar is acidic enough to erode tooth enamel and irritate your throat and esophagus, so it always gets diluted well in water and never gets thrown back as a shot. It is a supplement, not a cure.
Maltodextrin is a rapidly-digested glucose polymer made by partially hydrolyzing starch (usually corn, rice, or potato) into short chains of glucose units. Because it is broken down at the intestinal brush border into pure glucose and absorbed through SGLT1, it behaves like fast carbohydrate fuel with a very high glycemic index but lower osmolality than an equal weight of straight glucose. Athletes use it intra- and post-workout to keep blood glucose up, spare muscle glycogen, and refill glycogen stores after hard sessions.
Mosapride is a gastroprokinetic drug that acts as a selective agonist of the serotonin 5-HT4 receptor, used to improve the movement of the upper digestive tract. It is prescribed for conditions such as chronic gastritis, gastroesophageal reflux disease and functional dyspepsia, where sluggish stomach emptying contributes to symptoms. Marketed largely in Japan and other parts of Asia, it is noted for a favorable cardiac safety profile compared with the older prokinetic cisapride.
Pramlintide is a synthetic analogue of amylin, a peptide hormone released by the pancreas alongside insulin after meals. Given by injection at mealtimes, it is used together with insulin to improve blood-sugar control in people with type 1 or type 2 diabetes, chiefly by blunting the sharp rise in glucose that follows eating. Marketed as Symlin, it was approved by the United States FDA in 2005 and was the first new agent for lowering blood sugar in type 1 diabetes since insulin itself.